Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study

• Päätekijät: Ruiqiu Zhang (Tekijä), Liming Gao (Tekijä), Ping Chen (Tekijä), Weiguo Liu (Tekijä), Xin Huang (Tekijä), Xiao Li (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2023-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Objective: Acute kidney injury (AKI) is a common adverse reaction observed with the clinical use of cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium. Based upon real-world data, we will herein determine the risk factors associated with AKI in inpatients after receipt of these antimicro...